Theranostics and Precision Medicine for the Management of Hepatocellular Carcinoma, Volume 2: Diagnosis, Therapeutic Targets, and Molecular Mechanisms

1. Hepatocellular carcinoma diagnosis 2. Computational analysis of prognosisrelated genes in liver cancer 3. Computational approaches to identify biomarkers, enzymes, and pathways of hepatocellular carcinoma 4. Ribonucleic acid sequence analysis in deciphering hepatocellular carcinoma 5. Hepatocarcinogenesis and the role of next-generation sequencing in liver cancer 6. Liver cancer: the tumor microenvironment and associated pathways 7. Metabolic pathway-based target therapy to hepatocellular carcinoma: a computational approach 8. Targeting ion channels in hepatic cancer 9. Tyrosine kinases: their role in hepatocellular carcinoma 10. Role of transcription factors in hepatocellular carcinoma 11. Modulatory act of diverse transcriptional factors in liver carcinoma 12. Association of specificity protein 1 with hepatocellular carcinoma 13. Promising biomarkers for liver cancer 14. Molecular signaling and its role in drug resistance in hepatocellular carcinomas 15. Multidrug resistance, a major obstacle in hepatocellular carcinoma treatment: challenges and future perspectives 16. Proliferative signaling pathways in hepatocellular carcinoma 17. Targeting angiogenesis in hepatocellular carcinoma 18. Conventional and novel biomarkers for the diagnosis and prognosis of liver cancer 19. Updates on the staging and treatment of hepatocellular carcinoma 20. ROS-mediated pathways: potential role in hepatocellular carcinoma biology and therapy 21. Dysregulated cell-signaling pathways in hepatocellular carcinoma: causes and therapeutic options 22. LKB1/STK11-mediated signal transduction in hepatocellular carcinoma